Celeste Moss

@celestevmoss.bsky.social

df[TB]a! Tulsa, OK

🎥 The full picture: Imagine if a critical and effective HIV prevention medicine (lenacapavir) was more widely available. But instead, Gilead has priced the medicine out of reach, restricts its supply to certain countries, and refused to sell it directly to MSF. So people called it out.

Image featuring a large exhibition booth with signage displaying "Gilead" and "HIV" prominently. The top text in the graphic above the image reads, "35 mm: Pharmaceutical corporation makes a critical HIV prevention medicine." The bottom image shows the booth surrounded by a crowd, with the graphic text above the image reading, "IMAX 70mm: Pharmaceutical corporation gets called out by the people for pricing it out of reach. Gilead, let's talk."

YEZTUGO (lenacapavir) is a new injectable form of long-acting PrEP that only requires 2 doses per year to prevent HIV infection, and 3 million people are expected to get access to the drug by 2028 via The Global Fund. Sounds great, right? (1/5)

In celebration of #p4a2025 I’ve decided to raffle off some of my older pieces. Just comment with a screenshot of your donation, $1 = 1 entry. I will pick 2 winners randomly and ship within the US free of charge (see more info and a giveaway in the thread below)

BildBild